Insider filing · MAZE
Jason V Coloma
Chief Executive Officer
profile →
Maze Therapeutics, Inc.
MAZE · Healthcare · 41 filings in 24 months
ticker →
Jason V Coloma sold $783K of Maze Therapeutics (MAZE)
Executed May 22, disclosed May 27, 5 days later.
Value, as filed
$783K
30,086 sh across 2 lots
Executed
May 22
the trade date, as filed
Disclosed
May 27
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JCJason V Coloma (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $965K of MAZE (31,908 sh across 2 lots, as filed), executed Nov 2.
The name
MAZEHealthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jason V Coloma in MAZE
MAZESALE
Maze Therapeutics, Inc.
$965K31,908 sh across 2 lots
Exec Nov 2
Filed Nov 4 · 4:13 PM ET MAZESALE Maze Therapeutics, Inc. $862K
31,908 sh × $27.02
Exec Oct 1
Filed Oct 2 · 4:12 PM ET MAZESALE Maze Therapeutics, Inc. $553K
21,134 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:24 PM ET MAZESALE Maze Therapeutics, Inc. $810K
30,304 sh × $26.71
Exec Aug 3
Filed Aug 5 · 4:08 PM ET MAZESALE Maze Therapeutics, Inc. $908K
30,311 sh × $29.95
Exec Jul 1
Filed Jul 2 · 4:28 PM ET MAZESALE Maze Therapeutics, Inc. $622K
23,865 sh × $26.05
Exec Jun 23
Filed Jun 24 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $160K
6,090 sh × $26.20
Exec Jun 1
Filed Jun 3 · 5:30 PM ET